Biodistribution, radiation dosimetry and scouting of Y-90-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using Zr-89-ibritumomab tiuxetan and PET

S.N.F. Rizvi, O. Visser, M.J.W.D. Vosjan, A. van Lingen, O.S. Hoekstra, J.M. Zijlstra-Baalbergen, P.C. Huijgens, G.A.M.S. van Dongen, J.M. Lubberink

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)512-520
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume39
Issue number3
DOIs
Publication statusPublished - 2012

Cite this